A detailed history of Tower Research Capital LLC (Trc) transactions in Zai Lab LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,748 shares of ZLAB stock, worth $47,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,748
Previous 6,717 73.98%
Holding current value
$47,615
Previous $116,000 63.79%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.25 - $24.14 $80,746 - $119,951
-4,969 Reduced 73.98%
1,748 $42,000
Q2 2024

Aug 13, 2024

BUY
$13.72 - $21.55 $56,416 - $88,613
4,112 Added 157.85%
6,717 $116,000
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $877 - $1,474
55 Added 2.16%
2,605 $41,000
Q4 2023

Feb 13, 2024

BUY
$22.97 - $30.58 $55,679 - $74,125
2,424 Added 1923.81%
2,550 $69,000
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $192,279 - $266,499
-8,463 Reduced 98.53%
126 $3,000
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $8,576 - $13,448
-339 Reduced 3.8%
8,589 $238,000
Q1 2023

May 09, 2023

BUY
$30.21 - $48.1 $98,605 - $156,998
3,264 Added 57.63%
8,928 $297,000
Q4 2022

Feb 10, 2023

BUY
$22.28 - $38.71 $112,179 - $194,904
5,035 Added 800.48%
5,664 $174,000
Q3 2022

Nov 10, 2022

SELL
$34.2 - $51.69 $115,630 - $174,763
-3,381 Reduced 84.31%
629 $22,000
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $7,844 - $16,841
339 Added 9.23%
4,010 $140,000
Q1 2022

May 12, 2022

BUY
$27.77 - $64.4 $17,522 - $40,636
631 Added 20.76%
3,671 $161,000
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $79,879 - $153,080
1,455 Added 91.8%
3,040 $191,000
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $15,225 - $25,863
145 Added 10.07%
1,585 $167,000
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $119,104 - $171,360
952 Added 195.08%
1,440 $255,000
Q1 2021

May 17, 2021

SELL
$126.27 - $191.71 $128,669 - $195,352
-1,019 Reduced 67.62%
488 $65,000
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $91,690 - $151,445
1,119 Added 288.4%
1,507 $204,000
Q3 2020

Nov 16, 2020

BUY
$73.3 - $89.48 $16,492 - $20,133
225 Added 138.04%
388 $32,000
Q2 2020

Aug 13, 2020

BUY
$48.82 - $82.53 $7,957 - $13,452
163 New
163 $13,000
Q1 2020

May 15, 2020

SELL
$39.1 - $62.9 $89,148 - $143,412
-2,280 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$29.79 - $43.06 $58,328 - $84,311
1,958 Added 608.07%
2,280 $95,000
Q3 2019

Nov 05, 2019

BUY
$30.47 - $37.65 $3,382 - $4,179
111 Added 52.61%
322 $10,000
Q2 2019

Aug 13, 2019

SELL
$25.73 - $35.79 $49,993 - $69,539
-1,943 Reduced 90.2%
211 $7,000
Q1 2019

May 14, 2019

SELL
$21.71 - $31.54 $8,901 - $12,931
-410 Reduced 15.99%
2,154 $64,000
Q4 2018

Feb 14, 2019

BUY
$14.95 - $24.72 $38,331 - $63,382
2,564 New
2,564 $60,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.67B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.